HOME >> MEDICINE >> NEWS
Acrux and Oreganon further expand their collaboration

Drug delivery company Acrux (ASX: ACR), announced today that it has signed a further agreement with Organon, the human healthcare business unit of Akzo Nobel, expanding the two parties' collaboration. This follows the recently announced deal under which Organon and Acrux will develop and commercialise contraceptives, delivered through the skin using Acrux's unique spray technology.

Under the new agreement, Organon has licensed Acrux's technology for delivery of a non-hormone, proprietary Organon drug, for a substantial global women's health market.

"The expansion of our important relationship with Organon, one of the leading innovators in women's health, confirms that our unique spray technology has even broader potential" said Acrux CEO Richard Treagus.

"This adds a new, non-hormone drug to our pipeline and demonstrates the potential to use the technology to deliver drugs owned by our partners", he added.

Organon executive vice president, Research and Development, David Nicholson commented "The Acrux technology is an appealing method of delivering medication, with the potential to extend the choices available for women to fit their needs and lifestyle."

Acrux will be responsible for developing formulations of the undisclosed compound and upon successful completion; Organon will undertake and fund all clinical trials, regulatory submissions, manufacturing and commercialization efforts.

Acrux may receive payments totalling US$12 million as development and regulatory milestones are achieved.

Acrux will also earn royalties on worldwide sales of the product.


'"/>

Contact: Richard Treagus
richard.treagus@acrux.com.au
61-383-790-100
Research Australia
6-Mar-2007


Page: 1

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. Acrux granted first grant in Europe, triggering payment from Lilly
3. Acrux patent portfolio advances in USA
4. Acrux acquires rights to commercialise worlds first contraceptive spray
5. Four new us patents granted to Acrux for transdermal drug delivery
6. Acrux reports progress in development of Testosterone MD-Lotion(R) for men
7. Stomach cancer rate set to fall further 25 percent over next decade
8. High tech help to prevent further heart disease
9. Altered activity in receptor pair points to further complexity in schizophrenia pathology
10. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
11. Data further examines Seroquel (quetiapine fumarate) treatment for bipolar depression

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Acrux and Oreganon further expand their collaboration

(Date:11/18/2014)... OpenWorks, one of America’s leading commercial cleaning ... Guild Invitational. The John C. Lincoln Health Foundation holds ... Desert Mission community programs. Open Works was a Tee ... held at Camelback Golf Club in Scottsdale. More than ... Desert Mission — including a food bank, children's dental ...
(Date:11/18/2014)... As children head back to school and ... fall as the perfect time to refresh their looks ... County facial plastic surgeon, has observed a trend this ... Gallery of Cosmetic Surgery he has noticed an increase ... surgery procedures. , “Non-invasive cosmetic treatments give my ...
(Date:11/18/2014)... Thompson HealthDay Reporter , MONDAY, ... the verge of burning out are more likely to develop ... so-called vital exhaustion -- a toxic combination of fatigue, irritability ... developing heart disease, researchers report. "In our increasingly busy ... think, when that stress is left unchecked for a period ...
(Date:11/17/2014)... A Diet Doc in-house clinical ... country are turning back the clock on aging, looking ... because the company has recently added their prescription anti-aging ... of prescription and non-prescription diet products and healthy living ... best anti-aging human growth hormone therapy to ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 HIPAA Secure ... Noble Partners by members of the ASCII Group, a ... Awards were handed out at this year’s ASCII ... and a commitment to helping their peers grow successful ... received their awards at the Summit on October 23, ...
Breaking Medicine News(10 mins):Health News:OpenWorks Sponsors 2014 Lincoln Guild Invitational Golf Tournament Hosted by Scottsdale's Camelback Golf Club 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:The ASCII Group Names HIPAA Secure Now! Esteemed Noble Partner at ASCII Success Summit 2014 2Health News:The ASCII Group Names HIPAA Secure Now! Esteemed Noble Partner at ASCII Success Summit 2014 3
(Date:11/18/2014)... ResMed (NYSE: RMD ), a leading innovator in ... personal sleep monitoring device. ResMed today announced S+ availability through ... and from the Apple Online Store ( www.apple.com ). ... HealthKit in iOS8 to give consumers an easy-to-read, daily snapshot ... be shared with health care providers. "By ...
(Date:11/18/2014)... Nov. 18, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... Incorporated today announced the receipt of approval from the ... to market the IDEAL IMPLANT ® ... or replacement of existing augmentation implants. The FDA approval ... review of various studies and data including a U.S. ...
(Date:11/17/2014)... Ill. , Nov. 17, 2014  AbbVie (NYSE: ... Healthcare Conference in London on Thursday, ... and chief financial officer, will make a formal presentation on ... A live audio webcast of the presentation ... www.abbvieinvestor.com .  An archived edition of the session will ...
Breaking Medicine Technology:ResMed's New S+ Consumer Sleep Monitor Now Integrates With Apple HealthKit 2Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 2Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 3
Cached News: